Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Colburn

Showing results (141-150 of 216) with videos related to

Pageof 22
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|May 21, 2010
Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trialGerd Bobe, Paul S Albert, Leah B Sansbury, et al.
The Journal of Biological Chemistry|April 26, 1996
AP-1/jun is required for early Xenopus development and mediates mesoderm induction by fibroblast growth factor but not by activinZ Dong, R H Xu, J Kim, et al.
Oncogene|May 31, 2002
STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cellsCheng-Yong Yu, Lihua Wang, Alexander Khaletskiy, et al.
Molecular Carcinogenesis|April 1, 2005
A paracrine signal mediates the cell transformation response to low dose gamma radiation in JB6 cellsThomas J Weber, Robert W Siegel, Lye M Markillie, et al.
Journal of Biomolecular Screening|December 19, 2006
A high-throughput cell-based assay to identify specific inhibitors of transcription factor AP-1Katie M Ruocco, Ekaterina I Goncharova, Matthew R Young, et al.
Molecular and Cellular Biology|January 5, 2002
Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependentlyMatthew R Young, Rajalakshmi Nair, Natalie Bucheimer, et al.
Cancer Research|May 19, 2001
Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activationT C Hsu, R Nair, P Tulsian, et al.
Oncogene|February 25, 1999
Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformationR G Watts, C Huang, M R Young, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2016
Diallyl Disulfide (DADS), a Constituent of Garlic, Inactivates NF-κB and Prevents Colitis-Induced Colorectal Cancer by Inhibiting GSK-3βShakir M Saud, Weidong Li, Zane Gray, et al.
Oncogene|April 21, 2001
A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivationH S Yang, A P Jansen, R Nair, et al.
Pageof 22

Showing results (141-150 of 216) with videos related to

Sort By:
Pageof 22
Cancer Prevention Research (Philadelphia, Pa.)|May 21, 2010
Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trialGerd Bobe, Paul S Albert, Leah B Sansbury, et al.
The Journal of Biological Chemistry|April 26, 1996
AP-1/jun is required for early Xenopus development and mediates mesoderm induction by fibroblast growth factor but not by activinZ Dong, R H Xu, J Kim, et al.
Oncogene|May 31, 2002
STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cellsCheng-Yong Yu, Lihua Wang, Alexander Khaletskiy, et al.
Molecular Carcinogenesis|April 1, 2005
A paracrine signal mediates the cell transformation response to low dose gamma radiation in JB6 cellsThomas J Weber, Robert W Siegel, Lye M Markillie, et al.
Journal of Biomolecular Screening|December 19, 2006
A high-throughput cell-based assay to identify specific inhibitors of transcription factor AP-1Katie M Ruocco, Ekaterina I Goncharova, Matthew R Young, et al.
Molecular and Cellular Biology|January 5, 2002
Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependentlyMatthew R Young, Rajalakshmi Nair, Natalie Bucheimer, et al.
Cancer Research|May 19, 2001
Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activationT C Hsu, R Nair, P Tulsian, et al.
Oncogene|February 25, 1999
Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformationR G Watts, C Huang, M R Young, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2016
Diallyl Disulfide (DADS), a Constituent of Garlic, Inactivates NF-κB and Prevents Colitis-Induced Colorectal Cancer by Inhibiting GSK-3βShakir M Saud, Weidong Li, Zane Gray, et al.
Oncogene|April 21, 2001
A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivationH S Yang, A P Jansen, R Nair, et al.
Pageof 22